Literature DB >> 1799156

Gliomatosis cerebri: bioptical approach and neuropathological verification.

R Schober1, J K Mai, B Volk, W Wechsler.   

Abstract

Gliomatosis cerebri is rarely encountered and its intra vitam diagnosis has remained difficult. We present biopsy and autopsy findings in three cases that are representative of diffuse glioma, gliomatosis cerebri and diffuse glioblastosis, a modification of the subclassification proposed by Zülch31. Stereotactic biopsy in conjunction with nuclear magnetic resonance tomography (MRT) is recommended as the diagnostic procedure in suspected cases. Immunohistochemical examination with a panel of neuroectodermal markers is helpful in the differential diagnosis but has to take into account that reactive astrocytes may be closely intermingled with the neoplastic glial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1799156     DOI: 10.1007/BF01403198

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  20 in total

1.  Gliomatosis cerebri.

Authors:  J DUNN; J W KERNOHAN
Journal:  AMA Arch Pathol       Date:  1957-07

2.  [Problems of diffuse glioblastosis].

Authors:  W KAHLE
Journal:  Dtsch Z Nervenheilkd       Date:  1957

Review 3.  [Cerebral gliomatosis. An anatomoclinical case].

Authors:  M B Delisle; P Andrieu; G Geraud; H Bouissou
Journal:  Ann Pathol       Date:  1989       Impact factor: 0.407

4.  Leu-M1 immunoreactivity in the human brain. Discrimination between different tumors and between neoplastic and brain tissue.

Authors:  J Szymas; G Reifenberger; W Wechsler
Journal:  Naturwissenschaften       Date:  1987-04

5.  [Clinical diagnosis of diffuse gliomatosis].

Authors:  H Finkemeyer; T Tzonos
Journal:  Acta Neurochir (Wien)       Date:  1965       Impact factor: 2.216

Review 6.  Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system.

Authors:  G Reifenberger; J Szymas; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.

Authors:  C B Ostertag; B Volk; T Shibata; P Burger; P Kleihues
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

8.  Gliomatosis cerebri with formation of a glioblastoma multiform. Study and follow-up by magnetic resonance and computed tomography.

Authors:  F J Romero; A Ortega; F Titus; B Ibarra; C Navarro; M Rovira
Journal:  J Comput Tomogr       Date:  1988-10

9.  Diffuse cerebrospinal gliomatosis presenting as motor neuron disease for two years.

Authors:  M Schmidbauer; C Müller; I Podreka; B Mamoli; E Sluga; L Deecke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

10.  Diffuse gliomatosis of the central nervous system with histological features of microgliomatosis.

Authors:  H K Ng
Journal:  Clin Neuropathol       Date:  1988 Sep-Oct       Impact factor: 1.368

View more
  10 in total

1.  Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide.

Authors:  C Mawrin; V Aumann; E Kirches; R Schneider-Stock; C Scherlach; S Vogel; U Mittler; K Dietzmann; G Krause; S Weis
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.

Authors:  Stanley Yang; Stephan Wetzel; M Law; D Zagzag; Soonmee Cha
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

4.  Gliomatosis cerebri and pituitary adenoma: case report and literature review.

Authors:  A Mangiola; P De Bonis; M Guerriero; A Pompucci; C Anile
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  Gliomatosis cerebri in children. Case report and clinical considerations.

Authors:  Emanuela Caroli; Epimenio Ramundo Orlando; Luigi Ferrante
Journal:  Childs Nerv Syst       Date:  2005-01-27       Impact factor: 1.475

6.  Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri.

Authors:  Stefan Braeuninger; Regine Schneider-Stock; Elmar Kirches; James M Powers; David N Korones; Christian Mawrin
Journal:  J Neurooncol       Date:  2006-09-06       Impact factor: 4.130

7.  MR spectroscopy in gliomatosis cerebri.

Authors:  M Bendszus; M Warmuth-Metz; R Klein; R Burger; C Schichor; J C Tonn; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

8.  Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.

Authors:  Tomoo Inoue; Toshihiro Kumabe; Masayuki Kanamori; Yukihiko Sonoda; Mika Watanabe; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2011-02-08       Impact factor: 3.042

9.  Histological and MR correlations in Gliomatosis cerebri.

Authors:  Paule Peretti-Viton; Hervé Brunel; Olivier Chinot; Clément Daniel; Maryline Barrié; Corinne Bouvier; Dominique Figarella-Branger; Stéphane Fuentes; Henry Dufour; François Grisoli
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

10.  Presentation patterns and outcome of gliomatosis cerebri.

Authors:  Gustavo G Rajz; Dvora Nass; Elisa Talianski; Raphael Pfeffer; Roberto Spiegelmann; Zvi R Cohen
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.